Researchers at the George Washington University (GW) found that certain symptoms are more and less predictive of patients’ risk for acute coronary syndrome (ACS), which includes heart attack, in patients of different gender and race.
BTG plc recently highlighted the results of the ACCESS PTS trial, presented at the Society for Vascular Medicine 28th Annual Scientific Sessions, June 14-17 in New Orleans. The study found chronic deep vein thrombosis (DVT) patients with post-thrombotic syndrome (PTS) can be treated safely and effectively with Ekos therapy. The ACCESS PTS protocol using Ekos therapy is now the only treatment regimen proven to significantly reduce the signs and symptoms of PTS and show a significant improvement in quality of life, according to the company.
Sex-specific cardiovascular drug dosages are needed to reduce adverse reactions in women, according to a position paper from the European Society of Cardiology published in the June issue of European Heart Journal - Cardiovascular Pharmacotherapy.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
July 6, 2017 — New data showed use of Medtronic’s cardiac resynchronization therapy (CRT) devices with its proprietary ...
GE Additive and Stryker have entered a partnership agreement to support Stryker’s growth in additive manufacturing. The agreement covers new additive machines, materials and services for Stryker’s global supply chain operations. The announcement was made at GE’s Minds + Machines event, the company’s industrial internet event dedicated to software, innovation and the sharing of digital industrial outcomes.
Two predictive models may help cardiologists decide which patients would most benefit from an implantable cardioverter defibrillator (ICD), suggests a new study published in the Journal of the American College of Cardiology. According to the researchers, confirming the findings in a larger, randomized trial could lead to new national guidelines for choosing patients who are good candidates for ICD implantation.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Women and physicians do not put enough emphasis on cardiovascular disease in women, and a social stigma regarding body weight may be a primary barrier to these important discussions, according to new research. The findings were published in the Journal of the American College of Cardiology.
July 6, 2017 — GE Healthcare and HeartFlow Inc. announced at the annual scientific meeting of the Society of ...
Bayer has enrolled the first patient in a global Phase IV study assessing the clinical effects of riociguat in patients with pulmonary arterial hypertension (PAH). All enrolled patients were being treated with a Phosphodiesterase-5 inhibitors (PDE-5 inhibitors), either as monotherapy or in combination with an endothelin receptor antagonist (ERA), and who did not reach their therapeutic goal. The study, which is a part of the collaboration between Bayer and Merck, is seeking to enroll patients at 26 sites in the United States with a total of 100 study sites worldwide.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Michigan Medicine recently became the first healthcare institution in the United States to install the Artis pheno, the new robotic C-arm angiography system from Siemens Healthineers. The system is designed to broaden clinical capabilities and expand patient access while combating patient infection.
July 5, 2017 — BioStable Science & Engineering Inc. announced the first commercial uses of the HAART 300 Aortic ...
With worldwide cardiovascular deaths at an all-time high, European scientists have developed a new handheld scanner that can read the heart's vital signs like a supermarket barcode reader can scan items at the checkout. This would allow a general practitioner (GP) to diagnose even preclinical patients for the early onset of a disease.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Medtronic recently announced that its Reactive ATP therapy slows the progression of atrial fibrillation (AF) in patients with implanted cardiac devices. A robust, real-world analysis of nearly 8,800 patients was presented as a late breaking clinical trial at EHRA EUROPACE-CARDIOSTIM 2017, June 18-21 in Vienna, Austria.
When diagnosing strokes and heart diseases or looking at tumors, perfusion magnetic resonance imaging (MRI) offers a gentler way to capture the blood flow circulation in the organs. However, the method is far from being implemented to its full potential at many clinics. The Fraunhofer Institute for Medical Image Computing MEVIS in Bremen, Germany organized a workshop entitled “Measurement of Perfusion and Capillary Exchange” from June 21-23 to promote adoption of the method. The event provided information about its applications and the current state of research.
June 30, 2017 — Pulsed cavitation ultrasound can be used to remotely soften human degenerative calcified biosprosthetic ...
July 07, 2017
